Market Access Where Gross-to-net Pressure Actually Lives After Launch Drug ChannelsToday's guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.Read full story pharminent May 1, 2026 (Last updated: May 1, 2026) Drug Channels Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Two biotechs raise a combined $556M in latest spurt of IPOsNext: BMS brings the buzz around late-stage readouts amid a so-so Q1 Related Stories Market Access European study shows inequality in access to new medicines pharminent May 19, 2026 Market Access Deal finally unlocks NHS access to ITF’s Duchenne drug pharminent May 11, 2026 Market Access Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point pharminent May 5, 2026
